1. Introduction {#sec1-molecules-23-00289}
===============

*Aquilaria sinensis* (Lour.) Gilg. (Thymelaeaceae) is an evergreen tree endemic to China. The fragrant resin-infused wood derived from the wounded trees of *Aquilaria* species is called 'agarwood' or 'eaglewood'. Agarwood has been widely used as a traditional sedative, analgesic, and digestive medicine in China \[[@B1-molecules-23-00289]\]. Various benzenoids \[[@B2-molecules-23-00289]\], flavonoids \[[@B2-molecules-23-00289],[@B3-molecules-23-00289]\], 2-(2-phenylethyl)chromones \[[@B2-molecules-23-00289],[@B4-molecules-23-00289],[@B5-molecules-23-00289],[@B6-molecules-23-00289],[@B7-molecules-23-00289]\], sesquiterpenes \[[@B8-molecules-23-00289]\], steroids \[[@B2-molecules-23-00289],[@B7-molecules-23-00289]\], triterpenoids \[[@B5-molecules-23-00289]\], and their derivatives were isolated from this plant in previous studies. Many of these compounds exhibit anti-acetylcholinesterase \[[@B8-molecules-23-00289]\], anti-inflammatory \[[@B2-molecules-23-00289],[@B7-molecules-23-00289]\], antitumor \[[@B3-molecules-23-00289]\], and cytotoxic \[[@B6-molecules-23-00289]\] activities.

Aberrant activation of macrophages is related to many inflammatory disorders such as sepsis, neurodegenerative disorders, osteoporosis, cardiovascular and metabolic diseases \[[@B9-molecules-23-00289]\]. Nuclear factor κB (NF-κB) is an important transcription factor when stimulating an inflammatory reaction and as a molecular target for anti-inflammatory drug discovery. Lipopolysaccharide (LPS)-stimulated macrophages have been prevalently applied as an in vitro model system to study inflammation and to identify anti-inflammatory compounds \[[@B10-molecules-23-00289],[@B11-molecules-23-00289]\]. In our studies on the anti-inflammatory constituents of Formosan plants and Chinese herbal medicines, many species have been screened for in vitro inhibitory activity against NF-κB, a key transcriptional activator of pro-inflammatory molecules in LPS-activated macrophages, and *A. sinensis* was found to be an active species. Four new 2-(2-phenylethyl)-4*H*-chromen-4-one derivatives, namely 7-methoxy-2-\[2-(4′-hydroxyphenyl)- ethyl\]chromone (**1**), 7-hydroxy-2-\[2-(4′-methoxyphenyl)ethyl\]chromone (**2**), 5,6-dihydroxy-2-\[2-(3′-hydroxy-4′-methoxyphenyl)ethyl\]chromone (**3**), and 6-hydroxy-5-methoxy-2-(2-phenylethyl)- chromone (**4**), and nine known compounds **5**--**13** have been isolated from the resinous wood of *A. sinensis* and identified. Their structures are depicted in [Figure 1](#molecules-23-00289-f001){ref-type="fig"}. This paper describes the structural elucidation of the compounds numbered **1** through **4** and the inhibitory activities of all isolates on LPS-induced NF-κB activation of macrophages.

2. Results and Discussion {#sec2-molecules-23-00289}
=========================

2.1. Isolation and Structural Elucidation {#sec2dot1-molecules-23-00289}
-----------------------------------------

Chromatographic purification of the EtOAc-soluble fraction of a MeOH extract of resinous wood of *A. sinensis* on a silica gel column and preparative thin-layer chromatography (TLC) afforded four new (**1**--**4**) and nine known compounds (**5**--**13**) ([Figure 1](#molecules-23-00289-f001){ref-type="fig"}).

Compound **1** was obtained as brown plates. The molecular formula, C~18~H~16~O~4~, was deduced from a proton adduct ion at *m*/*z* 297.11224 \[M + H\]^+^ (calcd. 229.11214) in the HR-ESI-MS spectrum (positive-ion mode) and was supported by the ^1^H-, ^13^C-, and DEPT NMR data. IR absorptions for OH (3418 cm^−1^) and γ-pyrone (1634 and 1590 cm^−1^) functions were observed. The ^1^H-NMR spectrum of **1** showed the presence of a methoxy group at δ~H~ 3.91 (3H, s, MeO-7), four methylene protons at δ~H~ 2.86 (2H, t, *J* = 8.0 Hz, H-8′) and 2.98 (2H, t, *J* = 8.0 Hz, H-7′) and a olefinic proton at δ~H~ 6.07 (1H, s, H-3). Additionally a set of typical ABX coupling systems at δ~H~ 6.83 (1H, d, *J* = 2.0 Hz, H-8), 6.95 (1H, dd, *J* = 8.5, 2.0 Hz, H-6) and 8.08 (1H, d, *J* = 8.5 Hz, H-5) and *para*-disubstituted benzene protons at δ~H~ 6.76 (2H, d, *J* = 8.5 Hz, H-3′ and H-5′) and δ~H~ 7.06 (2H, d, *J* = 8.5 Hz, H-2′ and H-6′) were observed. The ^13^C-NMR spectrum of **1** displayed the presence of two methylene groups at δ~C~ 32.0 and 36.3, a trisubstituted double bond at δ~C~ 109.8 and 168.5, a methoxyl group at δ~C~ 56.1, and a carbonyl group at δ~C~ 177.9. Based on the above, **1** was deduced to be a 2-(2-phenylethyl)chromone derivative with a methoxyl and a hydroxyl groups. Two signals at δ~C~ 164.1 and 154.5 arising from *O*-bearing aromatic *C*-atoms were attributable to C-7 and C-4′ respectively, by related HMBC and comparison with a structurally similar compound **10**. The HMBC correlations ([Figure 2](#molecules-23-00289-f002){ref-type="fig"}) observed between OMe-7 (δ~H~ 3.91) and C-7 (δ~C~ 164.1), as well as NOESY correlations ([Figure 2](#molecules-23-00289-f002){ref-type="fig"}) observed between OMe-7 (δ~H~ 3.91) and H-8 (δ~H~ 6.83) and H-6 (δ~H~ 6.95), revealed that the methoxyl group was supposed to be positioned at C-7. Thus, the hydroxyl group should be linked to the last open position at C-4′. Consequently, the structure of **1** was determined to be 7-methoxy-2-\[2-(4′-hydroxyphenyl)ethyl\]chromone.

Compound **2** was isolated as a yellowish amorphous powder. The ESI-MS afford the quasi-molecular ion \[M + H\]^+^ at *m*/*z* 297, implying a molecular formula of C~18~H~17~O~4~, which was confirmed by the HR-ESI-MS (*m*/*z* 297.11227 \[M + H\]^+^, calcd. 297.11214). The IR spectrum showed the presence of OH (3210 cm^−1^) and γ-pyrone (1635 and 1600 cm^−1^) groups. The ^1^H- and ^13^C-NMR data of **2** were similar to those of 7-methoxy-2-\[2-(4′-hydroxyphenyl)ethyl\]chromone (**1**), except that the 7-OH and 4′-OMe \[δ~H~ 3.79 (3H, s)\] groups of **2** replaced the 7-OMe and 4′-OH groups of **1**. This was supported by NOESY correlations between OMe-4′ (δ~H~ 3.79)/H-3′ (δ~H~ 6.83) and OMe-4′ (δ~H~ 3.79)/H-5′ (δ~H~ 6.83) and by HMBC correlations between OMe-4′ (δ~H~ 3.79)/C-4′ (δ~C~ 158.3), H-5 (δ~H~ 8.02)/C-7 (δ~C~ 156.1), and H-6 (δ~H~ 7.09)/C-7 (δ~C~ 156.1). According to the above data, the structure of **2** was elucidated as 7-hydroxy-2-\[2-(4′-methoxyphenyl)ethyl\]chromone. This was further confirmed by the ^1^H--^1^H-COSY, NOESY ([Figure 3](#molecules-23-00289-f003){ref-type="fig"}), DEPT, HSQC, and HMBC ([Figure 3](#molecules-23-00289-f003){ref-type="fig"}) techniques.

Compound **3** was isolated as a yellowish amorphous powder. Its molecular formula, C~18~H~16~O~6~, was determined on the basis of the positive HRESIMS at *m*/*z* 329.10186 \[M + H\]^+^ (calcd. 329.10196) and this was supported by the ^1^H, ^13^C, and DEPT NMR data. The IR spectrum showed the presence of OH (3418 cm^−1^) and γ-pyrone (1634 and 1590 cm^−1^) groups. The ^1^H- and ^13^C-NMR data of **3** were similar to those of 3′,6-dihydroxy-4′-methoxy-2-(2-phenylethyl)chromone \[[@B7-molecules-23-00289]\], except that the 5-hydroxy group \[δ~H~ 12.50 (1H, s, D~2~O exchangeable)\] of **3** replaced H-5 of 3′,6-dihydroxy-4′-methoxy-2-(2-phenylethyl)chromone \[[@B7-molecules-23-00289]\]. This was supported by HMBC correlations between OH-5 (δ~H~ 12.50) and C-5 (δ~C~ 145.3), C-6 (δ~C~ 140.2), and C-10 (δ~C~ 111.0). The full assignment of ^1^H- and ^13^C-NMR resonances was supported by ^1^H--^1^H COSY, DEPT, HSQC, NOESY ([Figure 4](#molecules-23-00289-f004){ref-type="fig"}), and HMBC ([Figure 4](#molecules-23-00289-f004){ref-type="fig"}) spectral analyses. On the basis of the above data, the structure of **3** was elucidated as 5,6-dihydroxy-2-\[2-(3′-hydroxy-4′-methoxyphenyl)ethyl\]chromone.

Compound **4** was obtained as a yellowish amorphous powder. The molecular formula C~18~H~16~O~4~ was deduced from a sodium adduct ion at *m*/*z* 319.09395 \[M + Na\]^+^ (calcd. 319.09408) in the HRESI mass spectrum. The presence of a conjugated carbonyl group was revealed by the band at 1633 cm^−1^ in the IR spectrum, which was confirmed by the resonances at δ~C~ 177.5 in the ^13^C-NMR spectrum. The IR spectrum also revealed a hydroxy absorption at 3340 cm^−1^. Comparison of the ^1^H- and ^13^C-NMR data of **4** with those of 6-hydroxy-2-(2-phenylethyl)chromone (corylifol A) \[[@B12-molecules-23-00289]\] suggested that their structures are closely related, except that the 5-methoxy group \[δ~H~ 3.98 (3H, s); δ~C~ 62.8\] of **4** replaced H-5 of 6-hydroxy-2-(2-phenylethyl)chromone \[[@B12-molecules-23-00289]\]. This was supported by HMBC correlation between OMe-5 (δ~H~ 3.98) and C-5 (δ~C~ 143.5). The structure elucidation of **4** was supported by ^1^H--^1^H COSY and NOESY ([Figure 5](#molecules-23-00289-f005){ref-type="fig"}) experiments, and ^13^C-NMR assignments were confirmed by DEPT, HSQC, and HMBC ([Figure 5](#molecules-23-00289-f005){ref-type="fig"}) techniques.

2.2. Structure Identification of the Known Isolates {#sec2dot2-molecules-23-00289}
---------------------------------------------------

The known isolates were readily identified by a comparison of physical and spectroscopic data (UV, IR, ^1^H-NMR, \[α\]~D~, and MS) with corresponding authentic samples or literature values, and this included four sesquiterpenes, neopetasane (**5**) \[[@B13-molecules-23-00289]\], 7α-*H*-9(10)-ene-11,12-epoxy-8-oxoeremphilane (**6**) \[[@B13-molecules-23-00289]\], dehydrokaranone (**7**) \[[@B5-molecules-23-00289]\], and ligudicin C (**8**) \[[@B14-molecules-23-00289]\], and five 2-(2-phenylethyl)-4*H*-chromen-4-one derivatives, 2-(2-phenylethyl)chromone (**9**) \[[@B15-molecules-23-00289]\], 7-methoxy-2-(2-phenylethyl)chromone (**10**) \[[@B16-molecules-23-00289]\], 6,7-dimethoxy-2-(2-phenylethyl)chromone (**11**) \[[@B2-molecules-23-00289]\], 6,7-dimethoxy-2-\[2-(4′-methoxyphenyl)ethyl\]chro-mone (**12**) \[[@B17-molecules-23-00289]\], and 6-hydroxy-7-methoxy-2-(2-phenylethyl)chromone (**13**) \[[@B18-molecules-23-00289]\].

2.3. Biological Studies {#sec2dot3-molecules-23-00289}
-----------------------

LPS-activated macrophage serves as an in vitro model system to study inflammation \[[@B19-molecules-23-00289]\]. A LPS-responsive macrophage cell clone RAW264.7/Luc-P1 was previously established, in which the activity of NF-κB correlates with the expression of reporter gene (*luciferase*) \[[@B10-molecules-23-00289]\]. This RAW 264.7/Luc-P1 cell line has been successfully applied to identify anti-inflammatory compounds \[[@B10-molecules-23-00289],[@B19-molecules-23-00289]\]. Furthermore, LPS-mediated NF-κB activation leads to upregulation of pro-inflammatory molecules, such as NO, in macrophages \[[@B20-molecules-23-00289]\]. Thus, NO production is a hallmark of inflammatory responses. The anti-inflammatory activities of compounds isolated from the resinous wood of *A. sinensis* were evaluated by their abilities to suppress NF-κB activation in RAW 264.7/Luc-P1 cell line, their inhibitory activities are summarized in [Table 1](#molecules-23-00289-t001){ref-type="table"}. Andrographolide was used as positive control. Based on the results of our bioactivity assays, the following conclusions can be drawn: (a) 5,6-Dihydroxy-2-\[2-(3′-hydroxy-4′-methoxyphenyl)ethyl\]chromone (**3**), neopetasane (**5**), 7α-*H*-9(10)-ene-11,12-epoxy-8-oxoeremphilane (**6**), dehydrokaranone (**7**), 7-methoxy-2-(2-phenylethyl)chromone (**10**), 6,7-dimethoxy-2-(2-phenylethyl)chromone (**11**), and 6,7-dimethoxy-2-\[2-(4′-methoxyphenyl)ethyl\]chro-mone (**12**) can significantly inhibit LPS-induced NF-κB activation and did not show cytotoxicity against RAW 264.7/Luc-P1 cells after 24 h treatment (except compound **6** with dose-dependent cytotoxicity in RAW 264.7/Luc-P1 cells) ([Figure 6](#molecules-23-00289-f006){ref-type="fig"}A,C and [Figure 7](#molecules-23-00289-f007){ref-type="fig"}A,C); (b) among the chromone derivatives, 5,6-dihydroxy-2-\[2-(3′-hydroxy-4′-methoxyphenyl)ethyl\]chromone (**3**), 7-methoxy-2-(2-phenylethyl)chromone (**10**), 7-dimethoxy-2-(2-phenylethyl)chromone (**11**), and 6,7-dimethoxy-2-\[2-(4′-methoxyphenyl)ethyl\]chromone (**12**) could suppress LPS-induced NO production in RAW264.7 macrophages ([Figure 6](#molecules-23-00289-f006){ref-type="fig"}B) and did not induce cytotoxicity against RAW 264.7 cells after 24-h treatment ([Figure 6](#molecules-23-00289-f006){ref-type="fig"}D); (c) among the sesquiterpene analogues, neopetasan (**5**), 7α-*H*-9(10)-ene-11,12-epoxy-8-oxoeremphilane (**6**), dehydrokaranone (**7**) displayed no inhibitory activity on NO production in RAW264.7 macrophages ([Figure 7](#molecules-23-00289-f007){ref-type="fig"}B) and did not cause significant cytotoxicity ([Figure 7](#molecules-23-00289-f007){ref-type="fig"}D); (d) 6,7-dimethoxy-2-(2-phenylethyl)chromone (**11**) (with a 6-methoxy moiety) exhibited stronger inhibition than its analogue, 6-hydroxy-7-methoxy-2-(2-phenylethyl)chromone (**13**) (with a 6-hydroxy group); (e) 7-methoxy-2-(2-phenylethyl)chromone (**10**) (without the 4′-hydroxy moiety) exhibited more effective inhibition than its analogue, 7-methoxy-2-\[2-(4′-hydroxyphenyl)ethyl\]chromone (**1**) (with a 4′-hydroxy group); (f) 2-(2-phenylethyl)chromone (**9**) (without any substituents) exhibited no inhibitory activity; (g) among the sesquiterpene analogues **5**, **6**, and **8**, neopetasane (**5**) (with a prop-1-en-2-yl moiety at C-7) exhibited stronger inhibition than the analogues **6** and **8**; (h) 6,7-dimethoxy-2-(2-phenylethyl)chromone (**11**) was the most effective among the isolated compounds, with a relative luciferase activity value of 0.31 ± 0.05, against LPS-induced NF-κB activation in RAW 264.7/Luc-P1 cells.

It is noted that the inhibition on NO production is not always in a tight correlation with NF-κB activation (e.g., compounds **5**, **6**, and **7** in [Figure 7](#molecules-23-00289-f007){ref-type="fig"}B), which may be due to the discrepancy in experimental conditions and the sensitivity of assays used for measuring these two mediators. Alternatively, natural products are commonly known to be multiple-targeted, these compounds may be involved in NF-κB-independent NO regulation.

3. Experimental Section {#sec3-molecules-23-00289}
=======================

3.1. General Procedures {#sec3dot1-molecules-23-00289}
-----------------------

Melting points were determined on a Yanaco micro-melting point apparatus (Yanaco, Tokyo, Japan) and were uncorrected. Optical rotations were measured using a Jasco DIP-370 polarimeter (Japan Spectroscopic Corporation, Tokyo, Japan) in CHCl~3~. Ultraviolet (UV) spectra were obtained on a Jasco UV-240 spectrophotometer. Infrared (IR) spectra (KBr or neat) were recorded on a Perkin Elmer 2000 FT-IR spectrometer (Perkin Elmer Corporation, Norwalk, CT, USA). Nuclear magnetic resonance (NMR) spectra, including nuclear Overhauser effect spectrometry (NOESY), correlation spectroscopy (COSY), heteronuclear single-quantum coherence (HSQC), and heteronuclear multiple-bond correlation (HMBC) experiments, were acquired using a Varian VNMRS-600 or a Varian Inova 500 spectrometer (Varian Inc., Palo Alto, CA, USA) operating at 600 or 500 MHz (^1^H) and 150 or 125 MHz (^13^C), respectively, with chemical shifts given in ppm (δ) using tetramethylsilane (TMS) as an internal standard. Electrospray ionisation (ESI) and high-resolution electrospray ionization (HRESI)-mass spectra were recorded on a VG Platform Electrospray ESI/MS mass spectrometer (Fison, Villeurbanne, France) or a Bruker APEX II (Bruker, Bremen, Germany). Silica gel (70--230, 230--400 mesh, Merck, Darmstadt, Germany) was used for column chromatography (CC). Silica gel 60 F-254 (Merck, Darmstadt, Germany) was used for preparative thin-layer chromatography (PTLC) and thin-layer chromatography (TLC).

3.2. Plant Material {#sec3dot2-molecules-23-00289}
-------------------

The resinous wood of *Aquilaria sinensis* (Lour.) Gilg. (Thymelaeaceae) were collected from Chiayi County, Taiwan, in August 2015 and identified by J.-J. Chen. A voucher specimen (AS-201308) was deposited in the Faculty of Pharmacy, National Yang-Ming University, Taipei, Taiwan.

3.3. Extraction and Isolation {#sec3dot3-molecules-23-00289}
-----------------------------

The dried resinous wood (600 g) of *A. sinensis* was pulverized and extracted three times with MeOH (15 L each) for 3 days. The extract was concentrated under reduced pressure at 35 °C, and the residue (110 g) was partitioned between EtOAc and H~2~O (1:1) to provide the EtOAc-soluble fraction (fraction A; 65 g). Fraction A (65 g) was purified by CC (3.3 kg of SiO~2~, 70--230 mesh; *n*-hexane/acetone gradient) to afford 9 fractions: A1--A9. Fraction A1 (3.8 g) was subjected to CC (190 g of SiO~2~, 230--400 mesh; *n*-hexane/EtOAc 15:1--0:1, 650 mL-fractions) to give 10 subfractions: A1-1--A1-10. Part (70 mg) of fraction A1-6 was further purified by preparative TLC (SiO~2~; CHCl~3~/EtOAc 60:1) to obtain neopetasane (**5**, 5.2 mg) (R*~f~* = 0.69). Part (85 mg) of fraction A1-10 was further purified by preparative TLC (SiO~2~; CH~2~Cl~2~/EtOAc 15:1) to afford 7α-*H*-9(10)-ene-1,12-epoxy-8-oxoeremphilane (**6**, 5.4 mg) (R*~f~* = 0.67). Fraction A2 (4.8 g) was subjected to CC (240 g of SiO~2~, 230--400 mesh; *n*-hexane/EtOAc 10:1--0:1, 750 mL-fractions) to give 10 subfractions: A2-1--A2-10. Fraction A2-2 (327 mg) was purified by CC (16.5 g of SiO~2~, 230--400 mesh, CHCl~3~/acetone (30:1--0:1), 250 mL-fractions) to give eight sub-fractions: A2-2-1--A2-2-8. Fraction A2-2-2 (35 mg) was further purified by preparative TLC (SiO~2~; CH~2~Cl~2~/EtOAc 30:1) to yield dehydrokaranone (**7**, 4.1 mg) (R*~f~* = 0.60) and 2-(2-phenylethyl)chromone (**9**, 4.6 mg) (R*~f~* = 0.36). Fraction A2-8 (235 mg) was purified by CC (11.8 g of SiO~2~, 230--400 mesh, CHCl~3~/acetone (25:1--0:1), 200 mL-fractions) to give nine subfractions: A2-8-1--A2-8-9. Fraction A2-8-4 (30 mg) was further purified by preparative TLC (SiO~2~; CH~2~Cl~2~/EtOAc 15:1) to afford 7-methoxy-2-(2-phenylethyl)chromone (**10**, 3.4 mg) (R*~f~* = 0.43). Fraction A4 (7.3 g) was subjected to CC (365 g of SiO~2~, 230--400 mesh; CH~2~Cl~2~/acetone 10:1--0:1, 800 mL-fractions) to afford 12 subfractions: A4-1--A4-12. Part (125 mg) of fraction A4-7 was further purified by preparative TLC (SiO~2~; *n*-hexane/EtOAc 1:1) to yield 6,7-dimethoxy-2-(2-phenylethyl)chromone (**11**, 5.4 mg) (R*~f~* = 0.48) and ligudicin C (**8**, 5.7 mg) (R*~f~* = 0.35). Fraction A5 (7.7 g) was subjected to CC (385 g of SiO~2~, 230--400 mesh; *n*-hexane/EtOAc 5:1--0:1, 700 mL-fractions) to give 11 subfractions: A5-1--A5-11. Part (110 mg) of fraction A5-6 was further purified by preparative TLC (SiO~2~; CHCl~3~/acetone 20:1) to obtain 6,7-dimethoxy-2-\[2-(4′-methoxyphenyl)ethyl\]chromone (**12**, 8.2 mg) (R*~f~* = 0.62). Fraction A7 (7.2 g) was subjected to CC (360 g of SiO~2~, 230--400 mesh; *n*-hexane/acetone 4:1--0:1, 700 mL-fractions) to give 10 subfractions: A7-1--A7-10. Fraction A7-7 (515 mg) was purified by CC (25.5 g of SiO~2~, 230--400 mesh, CH~2~Cl~2~/EtOAc (10:1--0:1), 500 mL-fractions) to give eight subfractions: A7-7-1--A7-7-8. Fraction A7-7-2 (33 mg) was further purified by preparative TLC (SiO~2~; *n*-hexane/acetone 3:2) to obtain 7-methoxy-2-\[2-(4′-hydroxy-phenyl)ethyl\]chromone (**1**, 2.5 mg) (R*~f~* = 0.53), 7-hydroxy-2-\[2-(4′-methoxyphenyl)ethyl\]chromone (**2**, 2.8 mg) (R*~f~* = 0.47), and 6-hydroxy-7-methoxy-2-(2-phenylethyl)chromone (**13**, 3.9 mg) (R*~f~* = 0.43). Part (95 mg) of fraction A7-9 was further purified by preparative TLC (SiO~2~; CH~2~Cl~2~/MeOH 20:1) to yield 5,6-dihydroxy-2-\[2-(3′-hydroxy-4′-methoxyphenyl)ethyl\]chromone (**3**, 3.7 mg) (R*~f~* = 0.55). Fraction A8 (8.6 g) was subjected to CC (435 g of SiO~2~, 230--400 mesh; hexane/acetone 2:1--0:1, 900 mL-fractions) to afford 13 subfractions: A8-1--A8-13. Fraction A8-2 (620 mg) was purified by CC (31 g of SiO~2~, 230--400 mesh, *n*-hexane/EtOAc (3:1--0:1), 400 mL-fractions) to give seven subfractions: A8-2-1--A8-2-7. Part (82 mg) of fraction A8-2-6 was further purified by preparative TLC (SiO~2~; *n*-hexane/EtOAc 1:1) to obtain 6-hydroxy-5-methoxy-2-(2-phenylethyl)chromone (**4**, 4.4 mg) (R*~f~* = 0.48).

*7-Methoxy-2-\[2-(4′-hydroxyphenyl)ethyl\]chromone* (**1**): brown plates; m.p. 155--157 °C (CH~2~Cl~2~-MeOH); UV (MeOH): λ~max~ (log ε) = 219 (4.64), 247 (4.41), 282 (4.31), 302 (4.21) nm; IR (KBr): υ~max~ = 3418 (OH), 1634, 1590 (γ-pyrone) cm^−1^; ^1^H-NMR (CDCl~3~, 500 MHz): see [Table 2](#molecules-23-00289-t002){ref-type="table"}; ^13^C-NMR (CDCl~3~, 125 MHz): see [Table 3](#molecules-23-00289-t003){ref-type="table"}; ESI-MS: *m*/*z* = 297 \[M + H\]^+^; HR-ESI-MS: *m*/*z* = 297.11224 \[M + H\]^+^ (calcd. for C~18~H~17~O~6~, 297.11214).

*7-Hydroxy-2-\[2-(4′-methoxyphenyl)ethyl\]chromone* (**2**): yellowish amorphous powder; UV (MeOH): λ~max~ (log ε) = 222 (4.69), 251 (4.42), 303 (4.16) nm; IR (KBr): υ~max~ = 3210 (OH), 1635, 1600 (γ-pyrone) cm^−1^; ^1^H-NMR (CDCl~3~, 500 MHz): see [Table 2](#molecules-23-00289-t002){ref-type="table"}; ^13^C-NMR (CDCl~3~, 125 MHz): see [Table 3](#molecules-23-00289-t003){ref-type="table"}; ESI-MS: *m*/*z* = 297 \[M + Na\]^+^; HR-ESI-MS: *m*/*z* = 297.11227 \[M + H\]^+^ (calcd. for C~18~H~17~O~6~: 297.11214).

*5,6-Dihydroxy-2-\[2-(3′-hydroxy-4′-methoxyphenyl)ethyl\]chromone* (**3**): yellowish amorphous powder; UV (MeOH): λ~max~ (log ε) = 204 (4.83), 235 (4.52), 358 (3.68) nm; IR (KBr): υ~max~ = 3418 (OH), 1634, 1590 (γ-pyrone) cm^−1^; ^1^H-NMR (CDCl~3~, 500 MHz): see [Table 2](#molecules-23-00289-t002){ref-type="table"}; ^13^C-NMR (CDCl~3~, 125 MHz): see [Table 3](#molecules-23-00289-t003){ref-type="table"}; ESI-MS: *m*/*z* = 329 \[M + Na\]^+^; HR-ESI-MS: *m*/*z* = 329.10186 \[M + H\]^+^ (calcd. for C~18~H~17~O~6~: 329.10196).

*6-Hydroxy-5-methoxy-2-(2-phenylethyl)chromone* (**4**): yellowish amorphous powder; UV (MeOH): λ~max~ (log ε) = 203 (4.40), 238 (4.37), 334 (3.71) nm; IR (KBr): υ~max~ = 3340 (OH), 1633, 1609 (γ-pyrone) cm^−1^; ^1^H-NMR (CDCl~3~, 600 MHz): see [Table 2](#molecules-23-00289-t002){ref-type="table"}; ^13^C-NMR (CDCl~3~, 150 MHz): see [Table 3](#molecules-23-00289-t003){ref-type="table"}; ESI-MS: *m*/*z* = 319 \[M + Na\]^+^; HR-ESI-MS: *m*/*z* = 319.09395 \[M + Na\]^+^ (calcd. for C~18~H~16~O~4~Na: 319.09408).

3.4. Biological Assay {#sec3dot4-molecules-23-00289}
---------------------

The inhibitory effects of the isolated compounds on LPS-induced NF-κB activation in RAW 264.7/Luc-P1 macrophage were evaluated by measuring the luminescence resulted from luciferase activity in a concentration-dependent manner. The purity of the tested compounds was \>98% as identified by NMR and MS.

### 3.4.1. Cells and Culture Medium {#sec3dot4dot1-molecules-23-00289}

RAW 264.7/Luc-P1 cell was an LPS-responsive cell line with an integrated reporter gene (pELAM1-Luc). The cell line was cultured under conditions as described previously \[[@B10-molecules-23-00289]\]. The RAW 264.7/Luc-P1 cells were regularly cultured at 37 °C in 5% CO~2~ incubator in DMEM supplemented with 10% heat-inactivated BCS, 100 U/mL penicillin, 100 μg/mL streptomycin, 2 μM L-glutamine, and 1 mM sodium pyruvate.

### 3.4.2. Luciferase Reporter Assay {#sec3dot4dot2-molecules-23-00289}

The RAW 264.7/Luc-P1 cells (1.5 × 10^5^ cells in 24-well plates) were treated with isolated compounds, vehicle (0.1% DMSO) or the positive control (30 μM andrographolide) for 1 h and then LPS (10 ng/mL) for 23 h, collected, and analyzed using luciferase assays (Promega, Madison, WI, USA). Cell lysates (20 μL) were then mixed with 100 μL luciferin right before luminescence detection \[[@B11-molecules-23-00289]\]. The luminescence was measured with an Infinite^®^ 200 PRO (Tecan Group Ltd., Männedorf, Switzerland).

### 3.4.3. Cytotoxicity Assay {#sec3dot4dot3-molecules-23-00289}

The MTT assay was used according to a previously described method \[[@B21-molecules-23-00289]\]. RAW 264.7 cells or RAW 264.7/Luc-P1 cells (1 × 10^4^ cells) were seeded into 96-well plates and treated with compounds (**3**, **5**--**7**, and **10**--**12**) and 0.1% DMSO for 24 h.

### 3.4.4. Determination of Nitric Oxide (NO) Production {#sec3dot4dot4-molecules-23-00289}

RAW 264.7 cells (4 × 10^4^ cells) were seeded into 96-well plates and treated with compounds (**3**, **5**--**7**, and **10**--**12**) and 0.1% DMSO for 1 h, then incubated with LPS (1 μg/mL) for 23 h. The 100 μL of cell culture medium was incubated with 100 μL of Griess reagent at room temperature for 10 min. The absorbance was measured at 550 nm against a calibration curve with sodium nitrite (NaNO~2~) standards.

### 3.4.5. Statistical Analysis {#sec3dot4dot5-molecules-23-00289}

Data are shown as mean ± SD of three independent experiments. Statistical analysis was performed using ANOVA followed by post hoc Dunnett's test to compare between-group differences. Differences were considered as statistically significant when *p* \< 0.05.

4. Conclusions {#sec4-molecules-23-00289}
==============

Thirteen compounds, including four new 2-(2-phenylethyl)-4*H*-chromen-4-one derivatives **1**--**4** were isolated from the resinous wood of *A. sinensis*. The structures of these compounds were established on the basis of spectroscopic data. The activity assays revealed that compounds **3**, **5**--**7**, and **10**--**12** inhibited LPS-stimulated NF-κB activation with relative luciferase activity values of 0.74 ± 0.03, 0.55 ± 0.09, 0.75 ± 0.05, 0.72 ± 0.10, 0.54 ± 0.03, 0.31 ± 0.05, and 0.38 ± 0.14, respectively. Moreover, chromone derivatives could suppress LPS-induced NO production without causing significant cytotoxicity. Our study suggests that agarwood and its isolates (especially compound **11**) are worthy of further biomedical investigation and could be developed as potential candidates for the treatment or prevention of various inflammatory diseases. The structure-and-activity relationship (SAR) of these isolated compounds in term of anti-inflammatory activity certainly merits further investigation.
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The chemical structures of compounds **1**--**13** isolated from *A. sinensis.*

![](molecules-23-00289-g001a)

![](molecules-23-00289-g001b)

![Key NOESY (**A**) and HMBC (**B**) correlations of **1**.](molecules-23-00289-g002){#molecules-23-00289-f002}

![Key NOESY (**A**) and HMBC (**B**) correlations of **2**.](molecules-23-00289-g003){#molecules-23-00289-f003}

![Key NOESY (**A**) and HMBC (**B**) correlations of **3**.](molecules-23-00289-g004){#molecules-23-00289-f004}

![Key NOESY (**A**) and HMBC (**B**) correlations of **4**.](molecules-23-00289-g005){#molecules-23-00289-f005}

![The anti-inflammatory effects of chromone derivatives **3** and **10**--**12** on LPS-stimulated macrophages. (**A**) RAW264.7/Luc-P1 macrophages (1.5 × 10^5^ cells in 24-well plates) were treated with indicated chromone derivatives or 0.1% DMSO for 1 h, followed by LPS (1 μg/mL) treatment for 23 h. The luciferase activity of treated groups was measured; (**B**) RAW 264.7 macrophages (4 × 10^4^ cells in 96-well plates) were treated with indicated compounds or 0.1% DMSO for 1 h, followed by LPS (1 μg/mL) treatment 23 h. Culture supernatants were measured for the production of NO using Griess assays. Andro (andrographolide) is the positive control. Data are expressed as the mean ± SD from three independent experiments. Asterisk (\*) indicates significant difference versus LPS-treated vehicle control (*p* \< 0.05). The cell viability of RAW 264.7/Luc-P1 cells (1 × 10^4^ cells in 96-well plates) (**C**) and RAW 264.7 cells (1 × 10^4^ cells in 96-well plates) (**D**) incubated with chromone derivatives for 24 h was measured using MTT assay. Data are expressed as the mean ± SD from three independent experiments. Asterisk (\*) indicates significant difference versus vehicle control (*p* \< 0.05).](molecules-23-00289-g006){#molecules-23-00289-f006}

![The anti-inflammatory effects of sesquiterpene analogues **5**--**7** on LPS-stimulated macrophages. (**A**) RAW264.7/Luc-P1 macrophages (1.5 × 10^5^ cells in 24-well plates) were treated with indicated sesquiterpenes analogs or 0.1% DMSO for 1 h, followed by LPS (1 μg/mL) treatment for 23 h. The luciferase activity of treated groups was measured; (**B**) RAW 264.7 macrophages (4 × 10^4^ cells in 96-well plates) were treated with indicated compounds or 0.1% DMSO for 1 h, followed by LPS (1 μg/mL) treatment 23 h. Culture supernatants were measured for the production of NO using Griess assays. Andro (andrographolide) is the positive control. Data are expressed as the mean ± SD from three independent experiments. Asterisk (\*) indicates significant difference versus LPS-treated vehicle control (*p* \< 0.05). The cell viability of RAW 264.7/Luc-P1 cells (1 × 10^4^ cells in 96-well plates) (**C**) and RAW 264.7 cells (1 × 10^4^ cells in 96-well plates) (**D**) incubated with sesquiterpene analogs for 24 h was measured using MTT assay. Data are expressed as the mean ± SD from three independent experiments. Asterisk (\*) indicates significant difference versus vehicle control (*p* \< 0.05).](molecules-23-00289-g007){#molecules-23-00289-f007}
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###### 

The effects of compounds **1**--**13** from the resinous wood of *A. sinensis* on NF-κB activation in RAW 264.7/Luc-P1 cells.

  Compounds ^a^                     Relative Luciferase Activity
  --------------------------------- ------------------------------
  1                                 0.89 ± 0.05
  2                                 0.93 ± 0.06
  3                                 0.74 ± 0.03 \*
  4                                 0.92 ± 0.01
  5                                 0.55 ± 0.09 \*
  6                                 0.75 ± 0.05 \*
  7                                 0.72 ± 0.16 \*
  8                                 0.98 ± 0.07
  9                                 1.26 ± 0.40
  10                                0.54 ± 0.03 \*
  11                                0.31 ± 0.05 \*
  12                                0.38 ± 0.14 \*
  13                                1.09 ± 0.21
  LPS-treated vehicle control ^b^   1.03 ± 0.02
  Andrographolide ^d^               0.35 ± 0.17 \*

^a^ Compounds **1**--**13**: 30 μM. ^b^ Vehicle control: 0.1% DMSO. ^c^ Data are expressed as the mean ± SD from three independent experiments. \* indicates significant difference versus LPS (1 μg/mL)-treated vehicle control (*p* \< 0.05). ^d^ Andrographolide (30 μM) is the positive control.

molecules-23-00289-t002_Table 2

###### 

^1^H-NMR data for compounds **1**--**4** (δ in ppm, *J* in Hz).

  Position   1 ^a^                2 ^a^                3 ^a^                4 ^b^
  ---------- -------------------- -------------------- -------------------- --------------
  3          6.07 s               6.16 s               6.02 s               6.06 s
  5          8.08 d (8.5)         8.02 d (9.0)         --                   --
  6          6.95 dd (8.5, 2.0)   7.09 dd (9.0, 2.5)   --                   --
  7          --                   --                   7.28 d (9.0)         7.30 d (9.3)
  8          6.83 d (2.0)         6.84 d (2.5)         6.86 d (9.0)         7.14 d (9.3)
  2′         7.06 d (8.5)         7.13 d (8.5)         6.78 d (2.0)         7.20 d (7.8)
  3′         6.76 d (8.5)         6.83 d (8.5)         --                   7.30 t (7.8)
  4′         --                   --                   --                   7.22 t (7.8)
  5′         6.76 d (8.5)         6.83 d (8.5)         6.76 d (8.0)         7.30 t (7.8)
  6′         7.06 d (8.5)         7.13 d (8.5)         6.64 dd (8.0, 2.0)   7.20 d (7.8)
  7′         2.98 t (8.0)         3.05 t (8.0)         2.96 t (7.0)         3.04 t (7.8)
  8′         2.86 t (8.0)         2.96 t (8.0)         2.88 t (7.0)         2.88 t (7.8)
  OH-5       --                   --                   12.50 s              --
  OH-6       --                   --                   5.43 s               --
  OH-3′      --                   --                   5.58 s               --
  OMe-5      --                   --                   --                   3.98 s
  OMe-7      3.91 s               --                   --                   --
  OMe-4′     --                   3.79                 3.87 s               --

^a^ Measured in CDCl~3~ at 500 MHz. ^b^ Measured in CDCl~3~ at 600 MHz.
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###### 

^13^C-NMR data for compounds **1**--**4** (δ in ppm).

  Position   1 ^a^   2 ^a^   3 ^a^   4 ^b^
  ---------- ------- ------- ------- -------
  2          168.5   168.1   170.4   167.0
  3          109.8   110.3   108.2   110.5
  4          177.9   177.1   183.2   177.5
  5          127.2   125.2   145.3   143.5
  6          116.5   113.8   140.2   146.1
  7          164.1   156.1   121.6   120.7
  8          100.1   103.9   110.7   114.1
  9          158.1   156.6   144.0   151.4
  10         115.4   118.4   111.0   117.9
  1′         131.5   131.5   129.5   139.8
  2′         129.4   129.2   115.9   128.3
  3′         115.6   114.1   144.6   128.7
  4′         154.5   158.3   145.9   126.6
  5′         115.6   114.1   112.0   128.7
  6′         129.4   129.2   123.9   128.3
  7′         32.0    31.9    30.3    32.9
  8′         36.3    36.1    34.7    35.6
  OMe-5      --      --      --      62.8
  OMe-7      56.1    --      --      --
  OMe-4′     --      55.3    56.3    --

^a^ Measured in CDCl~3~ at 125 MHz. ^b^ Measured in CDCl~3~ at 150 MHz.

[^1]: These authors contributed equally to this work.
